Lise Lotte Gluud

Research output

Research output per year 2008 2014 2016 2017 2018 2019

• 44 Journal article
• 29 Review
• 2 Editorial
• 1 Comment/debate
• 2 More
  • 1 Conference abstract in journal
  • 1 Letter

Research output per year

Research output per year

Search results

• 2019

  Cardiometabolic effects of antidiabetic drugs in non-alcoholic fatty liver disease

  Rix, I., Steen Pedersen, J., Storgaard, H. & Gluud, L. L., Mar 2019, In: Clinical Physiology and Functional Imaging. 39, 2, p. 122-127 6 p.

  Research output: Contribution to journal › Review › peer-review

  • Non-alcoholic Fatty Liver Disease 100%
  • Hypoglycemic Agents 88%
  • Metabolic Syndrome 23%
  • Heart Failure 12%
  • Bibliographies 9%
  2 Citations (Scopus)

• Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease

  Niu, L., Geyer, P. E., Albrechtsen, N. J. W., Gluud, L. L., Santos, A., Doll, S., Treit, P. V., Holst, J. J., Knop, F. K., Vilsbøll, T., Junker, A., Sachs, S., Stemmer, K., Müller, T. D., Tschöp, M. H., Hofmann, S. M. & Mann, M., Mar 2019, In: Molecular Systems Biology. 15, 16 p., e8793.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Profiling 100%
  • Liver 95%
  • fatty liver 87%
  • Polymeric Immunoglobulin Receptors 85%
  • Plasma 76%
  55 Citations (Scopus)

  35 Downloads (Pure)

• Pulmonary dysfunction due to combination of extra-pulmonary causes and alveolar damage is present from first the day of hospital admission in the early phase of acute pancreatitis

  Chelliah, T., Werge, M., Merc, A-I., Bisgaard, T., Hansen, E. F., Hansen, E. F., Schmidt, P. N., Novovic, S. & Gluud, L. L., Jun 2019, In: Pancreatology. 19, 4, p. 519-523

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Pancreatitis 100%
  • Respiratory Function Tests 76%
  • Total Lung Capacity 68%
  • Vital Capacity 56%
  • Lung 55%
• 2018

  Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous Glucose

  Maagensen, H., Junker, A. E., Jorgensen, N. R., Gluud, L. L., Knop, F. K. & Vilsboll, T., 1 May 2018, In: Journal of Clinical Endocrinology & Metabolism. 103, 5, p. 2042-2049 8 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Non-alcoholic Fatty Liver Disease 100%
  • Bone Remodeling 95%
  • Marker 81%
  • Type 2 Diabetes Mellitus 69%
  • Glucose 68%
  9 Citations (Scopus)

• Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices

  Zacharias, A. P., Jeyaraj, R., Hobolth, L., Bendtsen, F., Gluud, L. L. & Morgan, M. Y., 2018, In: Cochrane Database of Systematic Reviews. 2018, 10, CD011510.

  Research output: Contribution to journal › Review › peer-review

  • Carvedilol 100%
  • Varicose Veins 82%
  • Fibrosis 54%
  • Confidence Intervals 31%
  • Hemorrhage 30%
  15 Citations (Scopus)

• Cerebral Blood Flow and Metabolism in Hepatic Encephalopathy - A Meta-Analysis

  Bjerring, P. N., Gluud, L. L. & Larsen, F. S., Sept 2018, In: Journal of Clinical and Experimental Hepatology. 8, 3, p. 286-293 8 p.

  Research output: Contribution to journal › Review › peer-review

  • Hepatic Encephalopathy 100%
  • Cerebrovascular Circulation 80%
  • Meta-Analysis 62%
  • Oxygen 19%
  • Acute Liver Failure 16%
  7 Citations (Scopus)

• Development and predictive validity of the cirrhosis-associated ascites symptom scale: A cohort study of 103 patients

  Riedel, A. N., Kimer, N., Jensen, A-S. H., Dahl, E. K., Israelsen, M., Aamann, L. & Gluud, L. L., 21 Apr 2018, In: World Journal of Gastroenterology. 24, 15, p. 1650-1657

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Ascites 100%
  • Fibrosis 75%
  • Cohort Studies 68%
  • Quality of Life 18%
  • Liver Diseases 12%
  1 Citation (Scopus)

  43 Downloads (Pure)

• Endoscopic Necrosectomy Through Percutaneous Self-Expanding Metal Stents May Be a Promising Additive in Treatment of Necrotizing Pancreatitis

  Thorsen, A., Borch, A. M., Novovic, S., Schmidt, P. N. & Gluud, L. L., 2018, In: Digestive Diseases and Sciences. 63, 9, p. 2456-2465 10 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Acute Necrotizing Pancreatitis 100%
  • Metals 65%
  • Stents 65%
  • Necrosis 48%
  • Cutaneous Fistula 18%
  6 Citations (Scopus)

• Evaluation of local instillation of antibiotics in infected walled-off pancreatic necrosis

  Werge, M., Novovic, S., Roug, S., Knudsen, J. D., Feldager, E., Gluud, L. L. & Schmidt, P. N., Sept 2018, In: Pancreatology. 18, 6, p. 642-646

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Acute Necrotizing Pancreatitis 100%
  • Anti-Bacterial Agents 49%
  • Drainage 16%
  • Superinfection 12%
  • Amphotericin B 10%
  5 Citations (Scopus)

• Extracorporeal shock wave lithotripsy for pancreatic duct stones: an observational study

  Haraldsson, S., Roug, S., Nøjgaard, C., Novovic, S., Gluud, L. L., Feldager, E. & Schmidt, P. N., 2 Nov 2018, In: Scandinavian Journal of Gastroenterology. 53, 10-11, p. 1399-1403

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Lithotripsy 100%
  • Pancreatic Ducts 95%
  • Observational Studies 65%
  • Analgesics 35%
  • Pain 33%
  2 Citations (Scopus)

• L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis

  Goh, E. T., Stokes, C. S., Sidhu, S. S., Vilstrup, H., Gluud, L. L. & Morgan, M. Y., 15 May 2018, In: Cochrane Database of Systematic Reviews. 5, 149 p., CD012410.

  Research output: Contribution to journal › Review › peer-review

  • ornithylaspartate 100%
  • Hepatic Encephalopathy 67%
  • Fibrosis 41%
  • Odds Ratio 36%
  • Confidence Intervals 33%
  30 Citations (Scopus)

• Medical interventions for prevention and treatment of hepatic encephalopathy in adults with cirrhosis: a network meta-analysis

  Bjerring, P. N., Morgan, M. Y., Vilstrup, H., Nielsen, S. M., Christensen, R. & Gluud, L. L., 21 Dec 2018, In: Cochrane Database of Systematic Reviews. 12, p. 1-28 28 p., CD013241.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Network Meta-Analysis 100%
  • Hepatic Encephalopathy 89%
  • Fibrosis 55%
  1 Citation (Scopus)

• Optimized thiopurine therapy before withdrawal of anti-tumour necrosis factor-α in patients with Crohn's disease

  Bohn Thomsen, S., Kiszka-Kanowitz, M., Theede, K., Gluud, L. L. & Mertz Nielsen, A., 2018, In: European Journal of Gastroenterology and Hepatology. 30, 10, p. 1155-1158 4 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Crohn Disease 100%
  • Tumor Necrosis Factor-alpha 74%
  • Leukocyte L1 Antigen Complex 61%
  • Recurrence 34%
  • Thioguanine 20%
  1 Citation (Scopus)

• Prognosis of patients with ascites after PleurX insertion: an observational study

  Riedel, A. N., Kimer, N., Hobolth, L. & Gluud, L. L., 4 Mar 2018, In: Scandinavian Journal of Gastroenterology. 53, 3, p. 340-344

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Ascites 100%
  • Observational Studies 78%
  • Paracentesis 49%
  • Fibrosis 28%
  • Peritonitis 12%
  5 Citations (Scopus)

• Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index

  Lo, B., Prosberg, M. V., Gluud, L. L., Chan, W., Leong, R. W., van der List, E., van der Have, M., Sarter, H., Gower-Rousseau, C., Peyrin-Biroulet, L., Vind, I. & Burisch, J., Jan 2018, In: Alimentary Pharmacology and Therapeutics. 47, 1, p. 6-15 10 p.

  Research output: Contribution to journal › Review › peer-review

  • Inflammatory Bowel Diseases 100%
  • Meta-Analysis 79%
  • Systematic Reviews 78%
  • Ulcerative Colitis 29%
  • Crohn Disease 28%
  23 Citations (Scopus)

• The role of Branched Chain Amino Acids in the treatment of hepatic Encephalopathy

  Dam, G., Aamann, L., Vistrup, H. & Gluud, L. L., Dec 2018, In: Journal of Clinical and Experimental Hepatology. 8, 4, p. 448-451 4 p.

  Research output: Contribution to journal › Review › peer-review

  • Branched Chain Amino Acids 100%
  • Hepatic Encephalopathy 91%
  • Ammonia 86%
  • Anabolic Agents 33%
  • Muscles 30%
  7 Citations (Scopus)

• Update on the Therapeutic Management of Hepatic Encephalopathy

  Kornerup, L. S., Gluud, L. L., Vilstrup, H. & Dam, G., 1 May 2018, In: Current Gastroenterology Reports. 20, 5, 6 p., 21.

  Research output: Contribution to journal › Review › peer-review

  • Hepatic Encephalopathy 100%
  • ornithine phenylacetate 35%
  • ornithylaspartate 29%
  • Rifaximin 25%
  • Fecal Microbiota Transplantation 24%
  9 Citations (Scopus)

  49 Downloads (Pure)
• 2017

  Banding ligation versus no intervention for primary prevention in adults with oesophageal varices

  Yong, C. W. K., Vadera, S., Morgan, M. Y. & Gluud, L. L., 2017, In: Cochrane Database of Systematic Reviews. 2017, 5, 12 p., CD012673.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Esophageal and Gastric Varices 100%
  • Primary Prevention 86%
  • Ligation 73%
  • Fibrosis 61%
  1 Citation (Scopus)

• Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials

  Hansen, M., Sonne, D. P., Mikkelsen, K. H., Gluud, L. L., Vilsbøll, T. & Knop, F. K., May 2017, In: Journal of Diabetes and its Complications. 31, 5, p. 918-927 10 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Bile Acids and Salts 100%
  • Type 2 Diabetes Mellitus 72%
  • Meta-Analysis 71%
  • Systematic Reviews 70%
  • Randomized Controlled Trials 64%
  29 Citations (Scopus)

• Branched-chain amino acids for people with hepatic encephalopathy

  Gluud, L. L., Dam, G., Les, I., Marchesini, G., Borre, M., Aagaard, N. K. & Vilstrup, H., 2017, In: Cochrane Database of Systematic Reviews. 2017, 5, 54 p., CD001939.

  Research output: Contribution to journal › Review › peer-review

  • Branched Chain Amino Acids 100%
  • Hepatic Encephalopathy 91%
  • Lactulose 20%
  • Odds Ratio 19%
  • Neomycin 19%
  24 Citations (Scopus)

• Effect of overweight and obesity on weight loss and length of stay in patients with walled-off pancreatic necrosis

  Rysgaard, S., Rasmussen, D., Novovic, S., Schmidt, P. N. & Gluud, L. L., Jun 2017, In: Nutrition. 38, p. 109-112 4 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Acute Necrotizing Pancreatitis 100%
  • Overweight 67%
  • Weight Loss 62%
  • Length of Stay 57%
  • Obesity 53%

• Endoscopic therapy and beta-blockers for secondary prevention in adults with cirrhosis and oesophageal varices (Protocol)

  Gluud, L. L. & Morgan, M. Y., 2017, In: Cochrane Database of Systematic Reviews. 2017, 6, 13 p., CD012694.

  Research output: Contribution to journal › Review › peer-review

  • Esophageal and Gastric Varices 100%
  • Secondary Prevention 81%
  • Fibrosis 61%
  • Therapeutics 13%
  2 Citations (Scopus)

• Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy

  Goh, E. T., Andersen, M. L., Morgan, M. Y. & Gluud, L. L., 26 Jul 2017, In: Cochrane Database of Systematic Reviews. 2017, 8, 81 p., CD002798.

  Research output: Contribution to journal › Review › peer-review

  • Flumazenil 100%
  • Hepatic Encephalopathy 89%
  • Fibrosis 55%
  • Placebos 51%
  • Randomized Controlled Trials 50%
  16 Citations (Scopus)

• Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes

  Storgaard, H., Cold, F., Gluud, L. L., Lauritsen, T. V. & Knop, F. K., Jun 2017, In: Diabetes, Obesity and Metabolism. 19, 6, p. 906-908

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon-Like Peptide-1 Receptor 100%
  • Pancreatitis 75%
  • Type 2 Diabetes Mellitus 58%
  • Placebos 53%
  • Randomized Controlled Trials 26%
  46 Citations (Scopus)

• Is double-blinding achievable in a placebo-controlled trial with the glucagon-like-peptide-1 receptor agonist liraglutide?

  Foghsgaard, S., Vedtofte, L., Bahne, E., Andreasen, C., Christiansen, L. K., Svare, J. A., Clausen, T. D., Mathiesen, E. R., Damm, P., Gluud, L. L., Knop, F. K. & Vilsboll, T., 2017, In: Diabetologia. 60, p. S369-S369

  Research output: Contribution to journal › Conference abstract in journal › Research

• Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference

  Foghsgaard, S., Andreasen, C., Vedtofte, L., Andersen, E. S., Bahne, E., Strandberg, C., Buhl, T., Holst, J. J., Svare, J. A., Clausen, T. D., Mathiesen, E. R., Damm, P., Gluud, L. L., Knop, F. K. & Lauritsen, T. V., 1 Jan 2017, In: Diabetes Care. 40, 1, p. 109-116 8 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Gestational Diabetes 100%
  • Non-alcoholic Fatty Liver Disease 96%
  • Waist Circumference 89%
  • Insulin Resistance 73%
  • Fibrosis 19%
  24 Citations (Scopus)

• Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): An attempted network meta-analysis

  Buzzetti, E., Kalafateli, M., Thorburn, D., Davidson, B. R., Thiele, M., Gluud, L. L., Del Giovane, C., Askgaard, G., Krag, A., Tsochatzis, E. & Gurusamy, K. S., 2017, In: Cochrane Database of Systematic Reviews. 2017, 3, 284 p., CD011646.

  Research output: Contribution to journal › Review › peer-review

  • Alcoholic Hepatitis 100%
  • Network Meta-Analysis 96%
  • Alcoholic Liver Diseases 90%
  • Liver Diseases 60%
  • Alcohols 54%
  14 Citations (Scopus)

• Physical exercise for people with cirrhosis

  Aamann, L., Dam, G., Rinnov, A., Vilstrup, H. & Gluud, L. L., 2017, In: Cochrane Database of Systematic Reviews. 2017, 6, 15 p., CD012678.

  Research output: Contribution to journal › Review › peer-review

  • Fibrosis 100%
  • Exercise 87%
  6 Citations (Scopus)

• Reply to: "Adding embolization to TIPS implantation: A better therapy to control bleeding from ectopic varices?"

  Trebicka, J. & Gluud, L. L., Jul 2017, In: Journal of Hepatology. 67, 1, p. 202-203

  Research output: Contribution to journal › Comment/debate › Research

  4 Citations (Scopus)

• Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial

  Kimer, N., Pedersen, J. S., Busk, T. M., Gluud, L. L., Hobolth, L., Krag, A., Møller, S., Bendtsen, F. & Copenhagen Rifaximin (CoRif) Study Group, 1 Feb 2017, In: Hepatology. 65, 2, p. 592-603

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Rifaximin 100%
  • Fibrosis 49%
  • Hemodynamics 48%
  • Placebos 45%
  • Venous Pressure 34%
  36 Citations (Scopus)

• Terlipressin versus other vasoactive drugs for hepatorenal syndrome

  Israelsen, M., Krag, A., Allegretti, A. S., Jovani, M., Goldin, A. H., Winter, R. W. & Gluud, L. L., 2017, In: Cochrane Database of Systematic Reviews. 2017, 9, 62 p., CD011532.

  Research output: Contribution to journal › Review › peer-review

  • Terlipressin 100%
  • Hepatorenal Syndrome 91%
  • Odds Ratio 27%
  • Pharmaceutical Preparations 26%
  • Octreotide 25%
  5 Citations (Scopus)

• Vaccines for preventing hepatitis B in healthcare workers (an updated protocol)

  Borch, A., Kolster, C., Gluud, C. & Gluud, L. L., 2017, In: Cochrane Database of Systematic Reviews. 2017, 6, 15 p., CD012695.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Hepatitis B Vaccines 100%
  • Health Personnel 68%
  4 Citations (Scopus)
• 2016

  Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

  Storgaard, H., Gluud, L. L., Bennett, C., Grøndahl, M. F., Christensen, M. B., Knop, F. K. & Vilsbøll, T., Nov 2016, In: PLOS ONE. 11, 11, 23 p., e0166125.

  Research output: Contribution to journal › Review › peer-review

  • sodium glucose cotransporter-2 inhibitors 100%
  • Sodium-Glucose Transporter 2 Inhibitors 66%
  • Sodium 65%
  • Symporters 63%
  • Diabetes 62%
  111 Citations (Scopus)

• Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia

  Junker, A. E., Gluud, L., Holst, J. J., Knop, F. K. & Vilsbøll, T., 1 May 2016, In: Journal of Internal Medicine. 279, 5, p. 485–493 9 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Incretins 100%
  • Non-alcoholic Fatty Liver Disease 82%
  • Fasting 61%
  • Type 2 Diabetes Mellitus 28%
  • Glucose 24%
  30 Citations (Scopus)

• Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis

  Rohde, U., Hedbäck, N., Gluud, L. L., Lauritsen, T. V. & Knop, F. K., 1 Mar 2016, In: Diabetes, Obesity and Metabolism. 18, 3, p. 300-5 6 p.

  Research output: Contribution to journal › Letter › peer-review

  • Type 2 Diabetes Mellitus 100%
  • Meta-Analysis 99%
  • Systematic Reviews 98%
  • Obesity 92%
  • Confidence Intervals 79%
  73 Citations (Scopus)

• Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease

  Junker, A. E., Gluud, L. L., van Hall, G., Holst, J. J., Knop, F. K. & Lauritsen, T. V., 1 Apr 2016, In: Journal of Hepatology. 64, 4, p. 908–915

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon-Like Peptide 1 100%
  • Non-alcoholic Fatty Liver Disease 91%
  • Glucagon 88%
  • Glucose 53%
  • Fasting 42%
  13 Citations (Scopus)

• Impaired Follistatin Secretion in Cirrhosis

  Rinnov, A. R., Plomgaard, P., Pedersen, B. K. & Gluud, L. L., Sept 2016, In: The Journal of clinical endocrinology and metabolism. 101, 9, p. 3395-3400 6 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Follistatin 100%
  • Fibrosis 51%
  • Liver Cirrhosis 40%
  • Glucagon 27%
  • Somatostatin 23%
  9 Citations (Scopus)

• Infection increases mortality in necrotizing pancreatitis: A systematic review and meta-analysis

  Werge, M., Novovic, S., Schmidt, P. N. & Gluud, L. L., 1 Sept 2016, In: Pancreatology. 16, 5, p. 698-707 10 p.

  Research output: Contribution to journal › Review › peer-review

  • Acute Necrotizing Pancreatitis 100%
  • Necrosis 58%
  • Meta-Analysis 56%
  • Systematic Reviews 56%
  • Mortality 38%
  48 Citations (Scopus)

• Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis

  Gluud, L. L., Vilstrup, H. & Morgan, M. Y., Sept 2016, In: Hepatology. 64, 3, p. 908-22 15 p.

  Research output: Contribution to journal › Review › peer-review

  • Disaccharides 100%
  • Hepatic Encephalopathy 91%
  • Numbers Needed To Treat 71%
  • Meta-Analysis 57%
  • Systematic Reviews 56%
  41 Citations (Scopus)

• Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis

  Gluud, L. L., Vilstrup, H. & Morgan, M. Y., 18 Apr 2016, In: Cochrane Database of Systematic Reviews. 4, p. 1-164 164 p., CD003044.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • lactitol 100%
  • Lactulose 77%
  • Disaccharides 74%
  • Hepatic Encephalopathy 68%
  • Fibrosis 42%
  33 Citations (Scopus)

• Risk factors for and impact of respiratory failure on mortality in the early phase of acute pancreatitis

  Dombernowsky, T., Kristensen, M. Ø., Rysgaard, S., Gluud, L. L. & Novovic, S., 1 Sept 2016, In: Pancreatology. 16, 5, p. 756-60 5 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Pancreatitis 100%
  • Respiratory Insufficiency 96%
  • Mortality 51%
  • Pulmonary Atelectasis 36%
  • Pneumonia 24%
  23 Citations (Scopus)

• Skal vi bruge tranexamsyre til øvre gastrointestinal blødning?

  Translated title of the contribution: Not AvailableGluud, L. L. & Miliam, P. B., 22 Aug 2016, In: Ugeskrift for Laeger. 178, 34, p. 1590 1 p., V68420.

  Research output: Contribution to journal › Editorial

• The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis

  Prosberg, M. V., Bendtsen, F., Vind, I., Petersen, A. M. & Gluud, L. L., 1 Dec 2016, In: Scandinavian Journal of Gastroenterology. 51, 12, p. 1407-1415 9 p.

  Research output: Contribution to journal › Review › peer-review

  • Gastrointestinal Microbiome 100%
  • Inflammatory Bowel Diseases 95%
  • Meta-Analysis 75%
  • Systematic Reviews 74%
  • Ulcerative Colitis 36%
  82 Citations (Scopus)
• 2015

  Acute kidney injury and hepatorenal syndrome in cirrhosis

  Egerod Israelsen, M., Gluud, L. L. & Krag, A., 1 Feb 2015, In: Journal of Gastroenterology and Hepatology. 30, 2, p. 236-43 8 p.

  Research output: Contribution to journal › Review › peer-review

  • Hepatorenal Syndrome 100%
  • Acute Kidney Injury 66%
  • Fibrosis 51%
  • Terlipressin 13%
  • Alcoholic Hepatitis 12%
  38 Citations (Scopus)

• Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases

  Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G. & Gluud, C., 29 May 2015, In: São Paulo medical journal = Revista paulista de medicina. 133, 2, p. 164-5 2 p.

  Research output: Contribution to journal › Review

• Branched-chain amino acids for people with hepatic encephalopathy

  Gluud, L. L., Dam, G., Les, I., Córdoba, J., Marchesini, G., Borre, M., Aagaard, N. K. & Vilstrup, H., 25 Feb 2015, In: Cochrane Database of Systematic Reviews. 9, p. 1-89 89 p., CD001939.

  Research output: Contribution to journal › Review › peer-review

  • Branched Chain Amino Acids 100%
  • Hepatic Encephalopathy 91%
  • Lactulose 20%
  • Odds Ratio 19%
  • Neomycin 19%
  11 Citations (Scopus)

• Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis

  Junker, A. E., Gluud, L. L., Holst, J. J., Knop, F. K. & Vilsbøll, T., 1 Oct 2015, In: Journal of Gastroenterology and Hepatology. 30, 10, p. 1522-8 7 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Fibrosis 100%
  • Incretins 87%
  • Glucose 84%
  • Glucose Intolerance 35%
  • Gastric Inhibitory Polypeptide 24%
  8 Citations (Scopus)

• Intestinal colonization with phylogenetic group B2 Escherichia coli related to inflammatory bowel disease: a systematic review and meta-analysis

  Petersen, A. M., Halkjær, S. I. & Gluud, L. L., 1 Oct 2015, In: Scandinavian Journal of Gastroenterology. 50, 10, p. 1199-207 9 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Inflammatory Bowel Diseases 100%
  • Meta-Analysis 79%
  • Systematic Reviews 78%
  • Escherichia coli 74%
  • Ulcerative Colitis 41%
  15 Citations (Scopus)

• Non-selective beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of randomized trials

  Thiele, M., Albillos, A., Abazi, R., Wiest, R., Gluud, L. L. & Krag, A., 1 Aug 2015, In: Liver International. 35, 8, p. 2009-16 8 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Hepatocellular Carcinoma 100%
  • Meta-Analysis 92%
  • Fibrosis 52%
  • Bacterial Translocation 23%
  • Numbers Needed To Treat 22%
  33 Citations (Scopus)

• Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis

  Fialla, A. D., Israelsen, M., Hamberg, O., Krag, A. & Gluud, L. L., 1 Sept 2015, In: Liver International. 35, 9, p. 2072-8 7 p.

  Research output: Contribution to journal › Review › peer-review

  • Alcoholic Hepatitis 100%
  • Meta-Analysis 53%
  • Fibrosis 53%
  • Systematic Reviews 53%
  • Confidence Intervals 43%
  52 Citations (Scopus)